• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Constitutes
© 2025 Longbridge|Disclaimer

Event Tracking

Dec14
Stance Capital LLC Increased Holdings in Gilead Sciences in Q2
12:43
Dec13
Gilead Sciences' CAR T therapy Yescarta shows sustained efficacy, stock undervalued
15:21
Dec12
Gilead Sciences and Arcus Biosciences halt phase III trial for gastric and esophageal cancer drugs
13:23
H.C. Wainwright Maintains Buy Rating for Vir Biotechnology with a Price Target of $15.00
11:42
NewEdge Advisors LLC Increased Holdings in Gilead Sciences
10:35
Alliancebernstein L.P. reduces its stake in Gilead Sciences
08:04